REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

Also called NCT07216170

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07216170
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07216170. Allocation not applicable; no masking; primary purpose treatment. Start 2026-12 (anticipated); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke
Acronym
REVIVE
Condition
Acute Ischemic Stroke
Intervention (Device)
SOFIA Flow 88 Aspiration Catheter
Lead sponsor
Microvention-Terumo, Inc. (class: industry)
Collaborator
Bright Research Partners (class: industry)

Record details

Record id
cardio:ct-nct07216170
Content hash
7dfa66472ff944955683dd8813cf4d3a6f820ca9afb32d48976f9fd6ebb0d35b